De Burlo Group Inc Vertex Pharmaceuticals Inc Transaction History

De Burlo Group Inc

$734 Million
Q2 2024

A detailed history of De Burlo Group Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, De Burlo Group Inc holds 48,565 shares of VRTX stock, worth $22.1 Million. This represents 3.1% of its overall portfolio holdings.

Number of Shares

48,565

Previous 40,040 21.29%

Holding current value

$22.1 Million

Previous $16.7 Million 36.0%

% of portfolio

3.1%

Previous 2.27%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $3.35 Million - $4.14 Million	8,525 Added 21.29%	48,565 $22.8 Million
Q1 2024 May 13, 2024	SELL	$407.69 - $446.08 $10.1 Million - $11 Million	-24,725 Reduced 38.18%	40,040 $16.7 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $241,798 - $259,158	715 Added 1.12%	64,765 $22.5 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $2.61 Million - $2.92 Million	8,310 Added 14.91%	64,050 $22.5 Million
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $1.91 Million - $2.15 Million	-6,680 Reduced 10.7%	55,740 $16.1 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $17.1 Million - $19.1 Million	62,420 New	62,420 $18.1 Million
Q2 2022 Aug 11, 2022	SELL	$234.96 - $292.55 $16.1 Million - $20 Million	-68,410 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $15.1 Million - $17.9 Million	68,410 New	68,410 $17.9 Million
Q4 2020 Feb 05, 2021	SELL	$207.01 - $276.09 $167,678 - $223,632	-810 Closed	0 $0
Q3 2020 Nov 05, 2020	SELL	$255.65 - $303.1 $18.9 Million - $22.5 Million	-74,110 Reduced 98.92%	810 $220,000
Q1 2020 May 07, 2020	BUY	$199.77 - $247.81 $183,788 - $227,985	920 Added 1.24%	74,920 $17.8 Million
Q4 2019 Feb 06, 2020	BUY	$166.71 - $223.91 $12.3 Million - $16.6 Million	74,000 New	74,000 $16.2 Million
Q2 2018 Aug 10, 2018	SELL	$145.72 - $169.96 $6.53 Million - $7.61 Million	-44,800 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$151.6 - $177.13 $4.08 Million - $4.76 Million	26,900 Added 150.28%	44,800 $7.3 Million
Q4 2017 Feb 08, 2018	SELL	$137.28 - $155.55 $2.43 Million - $2.75 Million	-17,700 Reduced 49.72%	17,900 $2.68 Million
Q3 2017 Nov 02, 2017	BUY	$148.13 - $162.24 $5.27 Million - $5.78 Million	35,600	35,600 $5.41 Million

Others Institutions Holding VRTX

# of Institutions

1,706

Shares Held

225M

Call Options Held

1.2M

Put Options Held

1.59M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $117B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of De Burlo Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on De Burlo Group Inc with notifications on news.

Account

De Burlo Group Inc Vertex Pharmaceuticals Inc Transaction History